Search
for
Sort by
Research 30 of 391
- Evaluation of MCV/RDW Ratio and Correlations with Ferritin in Telogen Effluvium Patients
- Molluscum Contagiosum in an Epidermoid Cyst
- 675 Hair loss in hephaestin knockout mice is associated with iron deficiency
- Decreased selenium intake and low plasma selenium concentrations leading to clinical symptoms in a child with propionic acidaemia
- THE RELATIONSHIP OF SERUM FERRITIN LEVELS, IN FEMALE PATIENTS WITH TELOGEN EFFLUVIUM: A CASE CONTROL STUDY
- Studies on nutritional deficiency in cows in El-Behera province
- REV7: a small but mighty regulator of genome maintenance and cancer development
- Why Do Promising Therapies Stall in Development and How Can We Move Them Forward?
- The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
- BPH: epidemiology and comorbidities.
- Partial biotinidase deficiency: Clinical and biochemical features
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- 1194: The Long Term Effects of Doxazosin, Finasteride, and the Combination on Sexual Function in Men Participating in the MTOPS Study
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED?
- Association of Frailty Index with Clinical BPH Progression and Serious Adverse Events: the MTOPS Trial
- PD23-06 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY
- 004 Post Finasteride Syndrome: is Dutasteride Unfairly Accused?
- 133 Female Post-Finasteride Syndrome: It’s Not Just A Man’s World
- 054 Post Finasteride Syndrome: Guess Who-Demographics from FDA Database
- 112 Post-Finasteride Syndrome – Outcomes of FDA Database
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Biallelic HEPHL1 variants impair ferroxidase activity and cause an abnormal hair phenotype
- The association between melasma and iron profile: a case-control study
- Gender difference in relationship between serum ferritin and 25-hydroxyvitamin D in Korean adults
- Clinical Development of Topoisomerase-Interactive Drugs
- Tissue Expansion in the Head and Neck